Cytarabine Iv/Sq/Intrathecal Injection Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 100 mg/mL(IV & SQ); 50 mg/mL(intrathecal use)
Reference Brands: DepoCyt(US)
Category: Blood Disorder
Cytarabine inhibits DNA synthesis by incorporating into DNA strands, disrupting cell replication. It effectively treats leukemia and lymphoma by targeting rapidly dividing cancer cells. Benefits include rapid tumor reduction, improved remission rates, and enhanced survival, making it a key chemotherapeutic agent in hematologic malignancies.
Product Description:
Cytarabine injection is approved in the US by the FDA and in the EU via EMA for treating leukemia and lymphoma. Regulatory approval requires a comprehensive dossier featuring clinical trial data, manufacturing quality, safety, efficacy, and pharmacovigilance plans. In the US, the FDA reviews detailed submissions, while EMA ensures compliance with regional standards. For expert guidance on dossier preparation, regulatory pathways, and successful market entry, visit PharmaTradz. Ensuring regulatory compliance is essential for the safe, effective, and timely approval of cytarabine injection worldwide, supporting optimal patient outcomes and expanded access in oncology treatments.
Cytarabine Iv/Sq/Intrathecal Injection — third party manufacturing & bulk supply
Cytarabine Iv/Sq/Intrathecal Injection is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Cytarabine Iv/Sq/Intrathecal Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Cytarabine Iv/Sq/Intrathecal Injection →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Anagrelide Hydrochloride
Strength:
0.5 mg
Form: Capsules
Reference Brands: Agrylin (USA)
View Details
Ferric Maltol
Strength:
30 mg
Form: Capsules
Reference Brands: Accrufer (USA), Feraccru (EU)
View Details
Lusutrombopag
Strength:
3 mg
Form: Tablets
Reference Brands: Mulpleta (USA), Mulpleo (EU)
View Details
Quick Response Guaranteed | Verified Suppliers
